Clinical Trials
3 trialsNCT04163432 2026-05-19
STAGGER
University of Utah
Phase 2 Active not recruiting
NCT06106802 2026-02-23
Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
Samsung Medical Center
Phase 2 Recruiting
NCT04646824 2020-12-02
Almonertinib With Chemotherapy in mEGFR NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown